✦ LIBER ✦

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

✍ Scribed by Schlenk, R F; Benner, A; Hartmann, F; del Valle, F; Weber, C; Pralle, H; Fischer, JTh; Gunzer, U; Pezzutto, A; Weber, W

Book ID: 110055544
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 146 KB
Volume: 17
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifungal usage in children undergoing

Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93

✍ T. Lehrnbecher; J. Kaiser; D. Varwig; J. Ritter; A. H. Groll; U. Creutzig; T. Kl 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 91 KB

Intensive consolidation versus oral main

Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

✍ Schlenk, R F; Fröhling, S; Hartmann, F; Fischer, J Th; Glasmacher, A; del Valle, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Significance of age in acute myeloid leu

Significance of age in acute myeloid leukemia patients younger than 30 years : A common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A

✍ Ursula Creutzig; Thomas Büchner; Maria C. Sauerland; Martin Zimmermann; Dirk Rei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

## Abstract ## BACKGROUND. Data on the impact of age in acute myeloid leukemia (AML) patients <30 years treated in pediatric and adult trials are scarce. ## METHODS. In all, 891 patients <18 years were treated in the pediatric trials AML‐BFM 93/98 and 290 adolescents and young adults (>16 to <30

The stem cell mobilizing capacity of pat

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

✍ Keating, S; Suciu, S; de Witte, T; Zittoun, R; Mandelli, F; Belhabri, A; Amadori 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Axl expression is associated with advers

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

✍ Rochlitz, C; Lohri, A; Bacchi, M; Schmidt, M; Nagel, S; Fopp, M; Fey, MF; Herrma 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Tandem versus single autologous peripher

Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial

✍ Chevallier, P; Fornecker, L; Lioure, B; Béné, M C; Pigneux, A; Recher, C; Witz, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 523 KB